Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (2) Beule, Dieter Dr. (2) Cakmak-Görür, Nese Dr. (1) Chekulaeva, Marina Dr. (1) Chen, Wei Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Dhamodaran, Arunraj (1) Franke, Vedran Dr. (2) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (6) Kammertöns, Thomas Dr. (5) Kolesnichenko, Marina Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lorenz, Felix Dr. (1) Marko, Lajos Dr. (1) Mathas, Stephan Dr. (8) Meyer, Irmtraud Margret Prof. Dr. (1) Nguyen, Tam Hoai Dr. (1) Ohler, Uwe Prof. Dr. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Rajewsky, Nikolaus Prof. Dr. (1) Rhein, Simone Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (9) Sommer, Christian (1) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (2) Woehler, Andrew Dr. (1) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (15) (-) Daniel, Peter Prof. Dr. (1) (-) Lusatis, Simone (1) (-) Biologie maligner Lymphome (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (15) Translational Bioinformatics (2) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) (-) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (4) 2015 (4) 2016 (4) 2017 (6) 2018 (4) (-) 2019 (6) 2021 (4) 2022 (6) 2023 (5) 2024 (2) 17 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Lusatis, SimoneBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 200420062019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Januar 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein 01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto 01. August 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster 01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Januar 2004 / Nat Immunol A cancer immunosurveillance controversy Z.H. Qin T. Blankenstein 01. Januar 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling 01. Januar 2004 / J Immunol Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-γ pathway but not IL-12 or IL-18 T.H. Wu C.N. Pabin Z.H. Qin T. Blankenstein M. Philip J. Dignam K. Schreiber H. Schreiber Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Januar 2004 / J Immunol Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of lymphotoxin alpha and in the combined absence of functional B and T cells H.J. Kim T. Kammertoens M. Janke O. Schmetzer Z. Qin C. Berek T. Blankenstein
01. Januar 2004 / Gene Ther Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization J. Westermann T. Nguyen-Hoai A. Mollweide G. Richter O. Schmetzer H.J. Kim T. Blankenstein B. Doerken A. Pezzutto
01. August 2004 / Immunity CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions L. Ohl M. Mohaupt N. Czeloth G. Hintzen Z. Kiafard J. Zwirner T. Blankenstein G. Henning R. Foerster
01. Juli 2004 / Eur J Immunol Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors M. Gladow W. Uckert T. Blankenstein
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Januar 2004 / Int J Cancer CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells J.A. Lindencrona S. Preiss T. Kammertoens T. Schueler M. Piechocki W.Z. Wei B. Seliger T. Blankenstein R. Kiessling
01. Januar 2004 / J Immunol Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-γ pathway but not IL-12 or IL-18 T.H. Wu C.N. Pabin Z.H. Qin T. Blankenstein M. Philip J. Dignam K. Schreiber H. Schreiber